A carregar...
Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
In France, more than 2.5 million patients are currently treated with levothyroxine, mainly as the marketed product Levothyrox(®). In March 2017, at the request of French authorities, a new formulation of Levothyrox(®) was licensed, with the objective of avoiding stability deficiencies of the old for...
Na minha lista:
| Publicado no: | Clin Pharmacokinet |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584220/ https://ncbi.nlm.nih.gov/pubmed/30949873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00747-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|